A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

University of Colorado Anschutz Medical Campus ( Site 1110), Aurora, Colorado, United States

University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1111), Miami, Florida, United States

University of Chicago ( Site 1108), Chicago, Illinois, United States

Dana Farber Cancer Institute ( Site 1105), Boston, Massachusetts, United States

John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack, New Jersey, United States

Roswell Park Cancer Institute ( Site 1107), Buffalo, New York, United States

Providence Portland Medical Center ( Site 1101), Portland, Oregon, United States

Sarah Cannon Research Institute ( Site 7001), Nashville, Tennessee, United States

Medical College of Wisconsin ( Site 1112), Milwaukee, Wisconsin, United States

Hospital Universitario Austral ( Site 2204), Pilar, Buenos Aires, Argentina

Sanatorio Parque ( Site 2203), Rosario, Santa Fe Province, Argentina

Princess Alexandra Hospital ( Site 5300), Woolloongabba, Queensland, Australia

Monash Health ( Site 5301), Clayton, Victoria, Australia

FALP ( Site 2100), Santiago, Region M. de Santiago, Chile

Pontificia Universidad Catolica de Chile ( Site 2102), Santiago, Region M. de Santiago, Chile

Bradfordhill ( Site 2101), Santiago, Region M. de Santiago, Chile

Beijing Cancer Hospital ( Site 5401), Beijing, Beijing Municipality, China

Fujian Cancer Hospital ( Site 5413), Fuzhou, Fujian, China

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Oncology ( Site 5403), Nanjing, Jiangsu, China

Shanghai Chest Hospital ( Site 5400), Shanghai, Shanghai Municipality, China

Shanghai Pulmonary Hospital ( Site 5405), Shanghai, Shanghai Municipality, China

West China Hospital of Sichuan University ( Site 5416), Chengdu, Sichuan, China

The First Affiliated Hospital, Zhejiang University ( Site 5404), Hangzhou, Zhejiang, China

Rambam Health Care Campus ( Site 3202), Haifa, Israel

Shaare Zedek Medical Center ( Site 3200), Jerusalem, Israel

Rabin Medical Center ( Site 3203), Petah Tikva, Israel

Sheba Medical Center ( Site 3201), Ramat Gan, Israel

Aichi Cancer Center ( Site 5000), Nagoya, Aichi-ken, Japan

National Cancer Center Hospital East ( Site 5001), Kashiwa, Chiba, Japan

Kansai Medical University Hospital ( Site 5004), Hirakata, Osaka, Japan

Cancer Institute Hospital of JFCR ( Site 5002), Koto, Tokyo, Japan

Seoul National University Hospital ( Site 5100), Seoul, South Korea

Severance Hospital, Yonsei University Health System ( Site 5102), Seoul, South Korea

Samsung Medical Center ( Site 5101), Seoul, South Korea

HOSPITAL CLÍNIC DE BARCELONA ( Site 3310), Eixample, Barcelona, Spain

Institut Català d'Oncologia - L'Hospitalet ( Site 3317), L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Clinico San Carlos... ( Site 3316), Madrid, Madrid, Comunidad de, Spain

Hospital Universitari Vall d'Hebron ( Site 3311), Barcelona, Spain

Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD ( Site 3315), Madrid, Spain

Hospital Universitario HM Sanchinarro ( Site 3313), Madrid, Spain

Hospital Universitario Virgen de la Victoria ( Site 3312), Málaga, Spain

National Cheng Kung University Hospital ( Site 5202), Tainan, Taiwan

Taipei Medical University Hospital ( Site 5201), Taipei, Taiwan

Hacettepe Universite Hastaneleri ( Site 3410), Ankara, Turkey (Türkiye)

Ankara Bilkent Sehir Hastanesi ( Site 3412), Ankara, Turkey (Türkiye)

National Institute for Health Research UCLH Clinical Research Facility ( Site 3902), London, London, City of, United Kingdom

The Clatterbridge Cancer Centre ( Site 3903), Liverpool, United Kingdom

The Christie NHS Foundation Trust ( Site 3901), Manchester, United Kingdom